<DOC>
	<DOC>NCT02685007</DOC>
	<brief_summary>The purpose of this study is to describe ease of use and satisfaction with application of the pre-rolled TachoSil in laparoscopic procedures within approved therapeutic indication as per Summary of Product Characteristics (SmPC).</brief_summary>
	<brief_title>RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study</brief_title>
	<detailed_description>The drug being observed in this study is called Tachosil. Tachosil is being used in open invasive surgery for use as a local haemostatic and tissue sealing. This study will look at the application and an overview on the ease of use of pre-rolled form of Tachosil in minimal invasive (laparoscopic) surgery, cost analysis along with the evaluation of participant's satisfaction with the product. The study will enroll approximately 120 participants who will be inpatients. A participant can be included in the study when the physician has decided to use pre-rolled TachoSil according to the local SmPC and after obtaining informed consent from the patient. Participants will be analyzed in a routine setting after surgery. Data from all participants will be collected from their files as well as study specific questions answered by the treating physician. This multi-center trial will be conducted in 12 Austrian centers. The overall recruitment period is expected for 1 year and six months. Participants will be analyzed from the date of surgery till their discharge from hospital.</detailed_description>
	<criteria>1 Inpatients planned for laparoscopic surgery, in the field of gynecology, urology and abdominal surgery where prerolled TachoSil was applied, 18 years or older. 1. Has contraindications, such as hypersensitivity to the active pharmaceutical ingredients or to other components of prerolled TachoSil according to the current SmPC. 2. Is participating in another clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>minimal invasive surgery</keyword>
</DOC>